Skip to content

Clinical trials

Diabetic Nephropathies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Country / region: Canada Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20061
20071
20101
20112
20123
20132
20143
20152
20172
20193
20202
20212
20222
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting4
Unknown status3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bayer3
Boehringer Ingelheim3
Pfizer3
Alessandro Doria2
Gilead Sciences2
Ottawa Hospital Research Institute2
AbbVie (prior sponsor, Abbott)1
Bristol-Myers Squibb1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies34
Diabetes Mellitus, Type 210
Renal Insufficiency, Chronic10
Kidney Diseases7
Diabetes Mellitus6
Diabetes Mellitus, Type 14
Diabetes Complications3
Heart Failure3
Hypertension3
Albuminuria2

Trials

Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.